A Randomized Pilot Study of Nuedexta for the Prevention and Modification of Disease Progression in Episodic Migraine
Phase of Trial: Phase II
Latest Information Update: 06 Apr 2018
Price : $35 *
At a glance
- Drugs Dextromethorphan/quinidine (Primary)
- Indications Migraine
- Focus Therapeutic Use
- 21 Mar 2017 Status changed from active, no longer recruiting to completed.
- 27 Dec 2016 Status changed from recruiting to active, no longer recruiting.
- 27 Dec 2016 Planned primary completion date changed from 1 Dec 2016 to 1 Mar 2017.